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Introduction. Lung cancer remains one of the most prevalent forms of cancer, with approximately 20 000 new cases reported every
year in Spain, and 18000 deaths due to this disease. Radiotherapy, with or without other therapeutic modalities, is an effective
treatment. Our objective was to report on the use of radiotherapy for lung cancer and its variability in our region during 2007.
Objective. To report on the use of radiotherapy for lung cancer, its variability in our region, and to compare our results with the
previous study done in 2004 (VARA-I) in our region and with other published data.
Methods. We reviewed the clinical records and radiotherapy treatment sheets of all patients undergoing radiotherapy for lung
cancer among patients diagnosed during 2007 in the 12 public hospitals in Andalusia. Data were gathered on hospital type,
patient type, radiotherapy treatment characteristics, histological type, and tumor stage.
Results. 3051 patientswere diagnosedwith lung cancer, but only 610 patients underwent initial radiotherapy (19.9%).Most patients
had stage III squamous cell lung cancer with good performance status and were treated with radical therapy. The majority of
patients with non-small and small cell lung cancer were treated with concomitant chemo-radiotherapy. The most common
regimen for patients treated with palliative intent was 30Gy (10 fractions×3Gy per fraction). The total irradiation rate was 19.6%
with signiﬁcant differences among provinces (range, 8.5–25.6%; p<0.001). These differences were signiﬁcantly correlated with
the geographical distribution of radiation oncologists (r=0.78; p=0.02). Our results were similar to other published data and
previous study VARA-I.
Conclusion. There is still excessive variability in the application of radiotherapy for lung cancer in our setting.
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Introduction. A simple clinical tool able to predict the probability of radio-induceddysphagia on inoperable lung cancer patients has
been designed. Its applicability may suppose the preventive therapeutic measures on patients with high probability to develop
it.
Objectives. Compare the real radio-induced acute dysphagia degree with the one obtained according to the MAASTRO Clinic
prediction model.
Methods. Retrospectively, the clinical data of 25 lung cancer patients in stages I–III treated with conformal radiotherapy with
radical intention, exclusively or associated with sequential or concomitant chemotherapy were collected. With this data (age,
gender, WHO performance status, mean esophageal dose (MED), maximum esophageal dose (MAXED) and overall treatment
time (OTT), the MAASTRO Clinic radio-induced acute dysphagia (RAD) prediction model (for G2 and G3) was applied and it was
compared with the real toxicity (CTV v3.0). The data was analyzed with the statistical program SPSS v.15.
Results. The sample media age was of 65 years. 19 patients (76%) were of male sex. The 84% (21) correspond to NSCLC and 16%
(4) to SCLC. The 88% (22) were stage III. Regarding to the treatment modality: 13(52%) received concomitant chemotherapy-
radiotherapy, while 10 (40%) sequential radiotherapy. Concerning to the RAD: 3(12%), 7(28%) and 13 (52%) correspond to G0, G1
and G2 respectively. There was not G3. The real toxicity was compared to the one obtained according to the predictive model,
nevertheless, no statistically signiﬁcant correlation was obtained.
Conclusions. In our series there is not statistically correlation between the real RAD and the one obtained applying the mentioned
predictive model. However, there is a clear tendency to reach it, especially, in relation to the II degree when it surpasses the 50%
of probability of observing it. We will continue recollecting data in order to expand the sample size and be able to demonstrate
the stated relationship.
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Introduction. Small Cell LungCancer (SCLC)makesupabout 15%of all lung cancer. This histology grouphave thepoorest prognostic
at this cancer site because its high tendency to local and regional recurrence and, mainly, distant metastases. Role of radiation
treatment exclusively or combined with chemotherapy, is uncertain.
